Clinical Trial Update: Paricalcitol Effect on Anemia in CKD [Phase 4]

View source ↗

Summary

This document reports the completion of a Phase 4 trial evaluating paricalcitol for anemia in chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• Paricalcitol (paricalcitol)

Snippet

Sponsor: Federico II University | Conditions: Anemia, Chronic Kidney Disease | Phase 4 | Status: COMPLETED